Hydroxymethylation at gene regulatory regions directs stem/early progenitor cell commitment during erythropoiesis.

Hematopoietic stem cell differentiation involves the silencing of self-renewal genes and induction of a specific transcriptional program. Identification of multiple covalent cytosine modifications raises the question of how these derivatized bases influence stem cell commitment. Using a replicative primary human hematopoietic stem/progenitor cell differentiation system, we demonstrate dynamic changes of 5-hydroxymethylcytosine (5-hmC) during stem cell commitment and differentiation to the erythroid lineage. Genomic loci that maintain or gain 5-hmC density throughout erythroid differentiation contain binding sites for erythroid transcription factors and several factors not previously recognized as erythroid-specific factors. The functional importance of 5-hmC was demonstrated by impaired erythroid differentiation, with augmentation of myeloid potential, and disrupted 5-hmC patterning in leukemia patient-derived CD34+ stem/early progenitor cells with TET methylcytosine dioxygenase 2 (TET2) mutations. Thus, chemical conjugation and affinity purification of 5-hmC-enriched sequences followed by sequencing serve as resources for deciphering functional implications for gene expression during stem cell commitment and differentiation along a particular lineage.

[1]  Tahlia L. Weis,et al.  Osteopontin Regulates Actin Cytoskeleton and Contributes to Cell Proliferation in Primary Erythroblasts* , 2008, Journal of Biological Chemistry.

[2]  K. Haldar,et al.  Stage-specific susceptibility of human erythroblasts to Plasmodium falciparum malaria infection. , 2009, Blood.

[3]  Luca Pinello,et al.  Combinatorial assembly of developmental stage-specific enhancers controls gene expression programs during human erythropoiesis. , 2012, Developmental cell.

[4]  Gonçalo R. Abecasis,et al.  Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of β-thalassemia , 2008, Proceedings of the National Academy of Sciences.

[5]  Yi Zhang,et al.  Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification , 2010, Nature.

[6]  K. Helin,et al.  Explorer TET 1 and hydroxymethylcytosine in transcription and DNA methylation fidelity , 2012 .

[7]  S. Keleş,et al.  Autophagy Driven by a Master Regulator of Hematopoiesis , 2011, Molecular and Cellular Biology.

[8]  Yinsheng Wang,et al.  A density functional theory study on the kinetics and thermodynamics of N-glycosidic bond cleavage in 5-substituted 2'-deoxycytidines. , 2012, Biochemistry.

[9]  Jungwon Huh,et al.  Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms. , 2009, Blood.

[10]  Z. Deng,et al.  The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes , 2011, Nature.

[11]  P. Opolon,et al.  TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. , 2011, Cancer cell.

[12]  D. Krause,et al.  Regulation of hematopoietic stem cell fate , 2002, Oncogene.

[13]  D. Page,et al.  Tet1 is dispensable for maintaining pluripotency and its loss is compatible with embryonic and postnatal development. , 2011, Cell stem cell.

[14]  D. Gilliland,et al.  Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. , 2009, Blood.

[15]  Riitta Lahesmaa,et al.  Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells. , 2011, Cell stem cell.

[16]  D. Williams,et al.  Cytokine regulation of hematopoietic stem cells. , 1991, Seminars in immunology.

[17]  L. Godley,et al.  Perturbations of 5-hydroxymethylcytosine patterning in hematologic malignancies. , 2013, Seminars in hematology.

[18]  P. Jin,et al.  Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine , 2011, Nature Biotechnology.

[19]  W. Reik,et al.  Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation , 2011, Nature.

[20]  Bin Wang,et al.  Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. , 2011, Cancer cell.

[21]  Yi Zhang,et al.  Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidation. , 2011, Genes & development.

[22]  J. Strouboulis,et al.  Role of Helix-Loop-Helix Proteins during Differentiation of Erythroid Cells , 2011, Molecular and Cellular Biology.

[23]  Yi Zhang,et al.  Tet1 and 5-hydroxymethylation , 2011, Cell cycle.

[24]  Zachary D. Smith,et al.  DNA methylation dynamics during in vivo differentiation of blood and skin stem cells. , 2012, Molecular cell.

[25]  J. Issa,et al.  Effects of TET2 mutations on DNA methylation in chronic myelomonocytic leukemia , 2012, Epigenetics.

[26]  David R. Liu,et al.  Conversion of 5-Methylcytosine to 5- Hydroxymethylcytosine in Mammalian DNA by the MLL Partner TET1 , 2009 .

[27]  G. Pfeifer,et al.  Reprogramming of the paternal genome upon fertilization involves genome-wide oxidation of 5-methylcytosine , 2011, Proceedings of the National Academy of Sciences.

[28]  K. Rajewsky,et al.  Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice , 2011, Proceedings of the National Academy of Sciences.

[29]  Henriette O'Geen,et al.  Discovering hematopoietic mechanisms through genome-wide analysis of GATA factor chromatin occupancy. , 2009, Molecular cell.

[30]  Feng-Chun Yang,et al.  Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies. , 2011, Blood.

[31]  J. Hirschhorn,et al.  DNA polymorphisms at the BCL11A, HBS1L-MYB, and β-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease , 2008, Proceedings of the National Academy of Sciences.

[32]  D. Gilliland,et al.  Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML , 2009, Leukemia.

[33]  Suhua Feng,et al.  5-Hydroxymethylcytosine is associated with enhancers and gene bodies in human embryonic stem cells , 2011, Genome Biology.

[34]  P. Sathyanarayana,et al.  During EPO or anemia challenge, erythroid progenitor cells transit through a selectively expandable proerythroblast pool. , 2010, Blood.

[35]  Christoph Bock,et al.  Global DNA Demethylation During Mouse Erythropoiesis in Vivo , 2011, Science.

[36]  W. Reik,et al.  5-Hydroxymethylcytosine in the mammalian zygote is linked with epigenetic reprogramming. , 2011, Nature communications.

[37]  J. Hirschhorn,et al.  Supporting Online Material Materials and Methods Figs. S1 to S10 Tables S1 to S7 References Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-specific Repressor Bcl11a , 2022 .

[38]  J. Greally,et al.  High Resolution Methylome Analysis Reveals Widespread Functional Hypomethylation during Adult Human Erythropoiesis* , 2013, The Journal of Biological Chemistry.

[39]  Bing Ren,et al.  Tet-assisted bisulfite sequencing of 5-hydroxymethylcytosine , 2012, Nature Protocols.

[40]  K. Rajewsky,et al.  Tet2 Negatively Regulates Homeostasis and Differentiation of Hematopoietic Stem Cells in Mice , 2011 .

[41]  Yihai Cao,et al.  PDGF-BB modulates hematopoiesis and tumor angiogenesis by inducing erythropoietin production in stromal cells , 2011, Nature Medicine.

[42]  Keji Zhao,et al.  Genome-wide analysis of 5-hydroxymethylcytosine distribution reveals its dual function in transcriptional regulation in mouse embryonic stem cells. , 2011, Genes & development.

[43]  J. Ulaszek,et al.  Differentiation stage-specific activation of p38 mitogen-activated protein kinase isoforms in primary human erythroid cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Y. Li,et al.  Chromatin boundaries require functional collaboration between the hSET1 and NURF complexes. , 2011, Blood.

[45]  M. Ogawa,et al.  Differentiation and proliferation of hematopoietic stem cells. , 1993, Blood.

[46]  I. Weissman,et al.  Clonal analysis of hematopoietic stem-cell differentiation in vivo. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[47]  A. Spradling,et al.  Stem cells find their niche , 2001, Nature.

[48]  Philipp Kapranov,et al.  Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells , 2011, Nature.

[49]  T. Townes,et al.  Targeted disruption of the activating transcription factor 4 gene results in severe fetal anemia in mice. , 2002, Blood.

[50]  N. Heintz,et al.  The Nuclear DNA Base 5-Hydroxymethylcytosine Is Present in Purkinje Neurons and the Brain , 2009, Science.

[51]  Timothy L Bailey,et al.  A global role for KLF1 in erythropoiesis revealed by ChIP-seq in primary erythroid cells. , 2010, Genome research.

[52]  O. Abdel-Wahab,et al.  Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. , 2011, Cancer cell.

[53]  Daniel E Bauer,et al.  Reawakening fetal hemoglobin: prospects for new therapies for the β-globin disorders. , 2012, Blood.